Home

Patient management

Read time: 3 min

Congress highlights

Mapping of early intervention programs for psychosis in France

Early intervention programs (EIPs) are widely considered to be effective for the treatment of...

Bipolar, Schizophrenia

Read time: 2 min

Congress highlights

IEPA 11 Opening Session: "Prevention & Early Intervention: Broadening the Scope"

World Mental Health Day is on 10 October 2018 and it will be marked by a variety of educational and...

Read time: 3 min

Congress highlights

Treating cognitive symptoms improves workplace productivity

The new paradigm for the treatment of major depressive disorder (MDD) is to “make patients...

Read time: 3 min

Congress highlights

Advances towards precision in psychiatry: “Dare, Share and Care”

We are moving towards an era in which treatments are tailored to patient subtypes. Professor Marion...

Read time: 4 min

Congress highlights

Niche no more: early use of long-acting injectable antipsychotics in schizophrenia

It is well known that early treatment of schizophrenia leads to better patient outcomes in the long...

Read time: 5 min

Satellite symposium

Can increased focus on patient perspectives improve outcomes in the treatment of schizophrenia?

Discordance between the treatment goals of patients and their clinicians is important, can lead to...

Read time: 4 min

Congress highlights

Functional recovery in depression: are we doing the right thing for the treatment of depression?

Major depressive disorder (MDD) is a heterogeneous disease characterized by many different mood,...

Parkinson's Disease

Read time: 4 min

Congress highlights

Non-motor symptoms – influencing ‘ON’ and ‘OFF’ in Parkinson’s disease

A broad spectrum of non-motor symptoms is highly prevalent in Parkinson’s disease (PD) which...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Towards new treatment options for MDD and schizophrenia: a role for D2 receptor partial agonists

Major depressive disorder (MDD) and schizophrenia share in common the side effect burden associated...

Read time: 3 min

Congress highlights

A “syndemic” relationship: Managing depression and diabetes

There is a high level of major depression among people with diabetes, and people with major...

Read time: 3 min

Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies

The results of an online survey completed by 204 US psychiatrists on the clinical impact of...

Bipolar, Schizophrenia

Read time: 4 min

Controversial issues in the management of schizophrenia

Controversial issues in the management of schizophrenia — brain shrinkage, dopamine...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country